U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
105751105751NICU-TECH RM9L-RS Probe ME Feasibility StudyCompletedNo Results AvailableNeonatesDevice: ultrasound probinghttps://ClinicalTrials.gov/show/NCT01181596
105752105752Tailored Internet-delivered Cognitive Behaviour Therapy for Symptoms of Depression and Comorbid ProblemsCompletedNo Results AvailableDepression|Anxiety DisordersBehavioral: Tailored Internet-delivered CBT|Behavioral: Non-tailored Internet-delivered CBT|Behavioral: Online discussion grouphttps://ClinicalTrials.gov/show/NCT01181583
105753105753Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sleep ApneaCompletedNo Results AvailablePsoriasis|Sleep Apnea, ObstructiveDrug: Adalimumab|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01181570
105754105754A Questionnaire to Assess the Quality of Life of Rectal Cancer Patients With or Without StomaCompletedNo Results AvailableRectal Cancerhttps://ClinicalTrials.gov/show/NCT01181557
105755105755A Pilot Study of a Heparin Dosing Algorithm for HemodialysisCompletedNo Results AvailableRenal Failure Chronic Requiring HemodialysisProcedure: Heparin dose titrationhttps://ClinicalTrials.gov/show/NCT01181544
105756105756Compare the Efficacy of Cinacalcet vs Traditional Vitamin D for Secondary Hyperparathyroidism (SHPT) Among Subjects Undergoing HemodialysisCompletedHas ResultsHyperparathyroidism, SecondaryDrug: Traditional Vitamin D Therapy|Drug: Cinacalcethttps://ClinicalTrials.gov/show/NCT01181531
105757105757Tamoxifen Pharmacogenetics in Asian Breast Cancer WomenRecruitingNo Results AvailablePoisoning by, Adverse Effect of and Underdosing of Tamoxifenhttps://ClinicalTrials.gov/show/NCT01181518
105758105758STUDY The Effect of HNF-4A G60D Variant on the In VIVO CYP2D6 Activity By Tolterodine Pharmacokinetic StudyCompletedNo Results AvailableGenotype Guided(HNF4a)|Healthy SubjectsDrug: Tolterodinehttps://ClinicalTrials.gov/show/NCT01181505
105759105759Impact of CYP3A4*1G Polymorphism on Metabolism of Fentanyl in Chinese Patients Undergoing Lower Abdominal SurgeryCompletedHas ResultsPain|Surgeryhttps://ClinicalTrials.gov/show/NCT01181492
105760105760Study to Evaluate the Contraceptive Efficacy/Safety of a Low Dose EE/LNG Transdermal Contraceptive Delivery SystemCompletedNo Results AvailableContraceptionDrug: AG200-15 transdermal patch|Drug: Oral Contraceptivehttps://ClinicalTrials.gov/show/NCT01181479
105761105761AeriSeal® System for Lung Volume Reduction in Patients With Advanced EmphysemaCompletedNo Results AvailablePulmonary Emphysema|COPD|Lung DiseasesDevice: AeriSeal Systemhttps://ClinicalTrials.gov/show/NCT01181466
105762105762Pivotal Trial of Dermagraft(R) to Treat Diabetic Foot UlcersCompletedNo Results AvailableDiabetic Foot UlcerDevice: Dermagraft|Other: Comparatorhttps://ClinicalTrials.gov/show/NCT01181453
105763105763Dermagraft(R) for the Treatment of Patients With Diabetic Foot UlcersCompletedNo Results AvailableDiabetic Foot UlcerDevice: Dermagraft(R)|Other: Conventional carehttps://ClinicalTrials.gov/show/NCT01181440
105764105764Study of ABT-267 in Both Healthy Volunteers and Hepatitis C Virus (HCV) Genotype 1 Infected SubjectsCompletedNo Results AvailableHCV InfectionDrug: ABT-267|Drug: Placebo|Procedure: Blood Sample Collection|Drug: Cytochrome P450 inhibitorhttps://ClinicalTrials.gov/show/NCT01181427
105765105765Spanish Atrial Fibrillation And Resynchronization StudyCompletedNo Results AvailableChronic Heart Failure|Cardiomyopathy, Dilated|Atrial FibrillationProcedure: Atrio ventricular junction ablation with radio-frequency|Drug: Beta blocker/digoxine/amiodaronehttps://ClinicalTrials.gov/show/NCT01181414
105766105766InductionChemo-Radio-Antibody-TreatmentRecruitingNo Results AvailableSquamous Cell Carcinoma of the Head|Squamous Cell Carcinoma of the NeckDrug: TPF induction chemotherapy|Drug: TPF experimental|Radiation: Standard Radiochemotherapy (HART)https://ClinicalTrials.gov/show/NCT01181401
105767105767Impacts of Superselective Infarct-related Artery (IRA) Infusion of Tirofiban on Myocardial Reperfusion and Bleeding Complications in Acute Myocardial Infarction (AMI) PatientsRecruitingNo Results AvailableMyocardial InfarctionProcedure: administration of tirofiban by thrombus aspiration catheter in infarct-related artery|Procedure: administration of tirofiban by guide catheterhttps://ClinicalTrials.gov/show/NCT01181388
105768105768Predictive Assays In Cervix CancerActive, not recruitingNo Results AvailableCervical CancerOther: Tumour Biopsies and Blood Samplinghttps://ClinicalTrials.gov/show/NCT01181375
105769105769Comparing Head and Neck Endoscopy ProceduresCompletedNo Results AvailableComparing Head And Neck Endoscopy in Healthy PatientsProcedure: Endoscopyhttps://ClinicalTrials.gov/show/NCT01181362
105770105770Incidence of Incomplete Postoperative Neuromuscular Recovery From Anesthesia (P07535)(Completed)CompletedHas ResultsNeuromuscular BlockadeOther: Neuromuscular Blocking Agent (NMBA)|Other: Neuromuscular Blocking Agent (NMBA)https://ClinicalTrials.gov/show/NCT01181349
105771105771Phase 1b Influenza Vaccine Study in Healthy SubjectsCompletedNo Results AvailableInfluenzaBiological: Influenza vaccine (FLU-v)|Biological: FLU-v Controlhttps://ClinicalTrials.gov/show/NCT01181336
105772105772Post-Partum Immunization With Live Attenuated Influenza Vaccine (LAIV) or Trivalent Influenza Vaccine (TIV) in Post-Partum Breast Feeding WomenCompletedHas ResultsInfluenzaOther: Placebo|Biological: Cold-adapted live attenuated influenza virus vaccine, trivalent|Other: Placebo|Biological: Trivalent inactivated influenza vaccinehttps://ClinicalTrials.gov/show/NCT01181323
105773105773Placebo-Controlled Crossover Study to Evaluate Donepezil and MK-3134 for Reversal of Cognitive Impairment Associated With Scopolamine Administration (3134-005)(COMPLETED)CompletedNo Results AvailableDementiaDrug: A: Placebo to match Donepezil and MK-3134 + Placebo to match Scopolamine|Drug: B: Placebo to match Donepezil and MK-3134 + Scopolamine 0.5 mg|Drug: C: MK-3134 25 mg + Scopolamine 0.5 mg|Drug: D: Donepezil 10 mg + Scopolamine 0.5 mg|Drug: E: Combo: Donepezil 10 mg + MK-3134 25 mg + Scopolamine 0.5 mghttps://ClinicalTrials.gov/show/NCT01181310
105774105774Double Blind Controlled Trial of an Extensively Hydrolyzed Formula With a Probiotic vs. an Extensively Hydrolyzed Formula Without a ProbioticCompletedNo Results AvailableAllergyOther: Extensively Hydrolyzed Formula with a Probiotic|Other: Extensively Hydrolyzed Formula without a Probiotichttps://ClinicalTrials.gov/show/NCT01181297
105775105775Modulating Effects of Lisinopril on Sildenafil Activity in Pulmonary Arterial Hypertension(PAH)( MELISSA)CompletedNo Results AvailablePulmonary Arterial Hypertensionhttps://ClinicalTrials.gov/show/NCT01181284
105776105776Tandem Auto-Allo Transplant for LymphomaActive, not recruitingNo Results AvailableDiffuse, Large B-Cell, Lymphoma|Lymphoma, Low-Grade|T-Cell Lymphoma|Mantle-Cell Lymphoma|Hodgkin's Lymphoma|Chronic Lymphocytic Leukemia|Lymphoma, Small LymphocyticDrug: Busulfan|Drug: Etoposide|Drug: Cyclophosphamide|Drug: Mesna|Drug: Phenytoin|Drug: Ursodiol|Other: Infusion of autologous peripheral blood stem cells|Drug: Neupogen|Drug: Fludarabine|Drug: Busulfan|Other: Peripheral blood stem cell transplant|Drug: Tacrolimus|Drug: Sirolimus|Drug: Methotrexatehttps://ClinicalTrials.gov/show/NCT01181271
105777105777Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid MalignanciesRecruitingNo Results AvailableNon-Hodgkin Lymphoma|Chronic Lymphocytic LeukemiaDrug: Rituximab|Biological: Interleukin-2|Biological: Natural killer cells|Drug: Cyclophosphamide|Drug: Methylprednisolone|Drug: Fludarabinehttps://ClinicalTrials.gov/show/NCT01181258
105778105778A Phase 1 Study of Safety and Bioactivity With FG-3019 in Combination With Gemcitabine and Erlotinib for Subjects With Locally Advanced or Metastatic Pancreatic CancerCompletedNo Results AvailableLocally Advanced or Metastatic Pancreatic CancerDrug: FG-3019https://ClinicalTrials.gov/show/NCT01181245
105779105779A Study to Compare Efficacy and Safety of Zolpidem Modified Release Formulation Versus Zolpidem in Insomnia PatientsCompletedNo Results AvailableSleep Initiation and Maintenance Disorders|Primary InsomniaDrug: Zolpidem MR|Drug: Zolpidem IRhttps://ClinicalTrials.gov/show/NCT01181232
105780105780Transepithelial Corneal Collagen Cross-linking (CXL) in Treatment of KeratoconusCompletedNo Results AvailableKeratoconusProcedure: CXL without epithelial removal|Procedure: CXL with epithelial removalhttps://ClinicalTrials.gov/show/NCT01181219

* Görseller ve İçerik tekif hakkına sahip olabilir